Table 1.
Frequency of the pathogenic GGGGCC hexanucleotide repeat expansion of C9orf72 in patients diagnosed with sporadic ALS or sporadic FTD classified by region
Sporadic ALS |
Sporadic FTD |
||||||
---|---|---|---|---|---|---|---|
n | Carriers | % (95% CI) | n | Carriers | % (95% CI) | ||
Europe* | |||||||
Finnish | 289 | 61 | 21·1% (16·5–26·3) | 48 | 9 | 18·8% (8·9–32·6) | |
Swedish | .. | .. | .. | 6 | 0 | 0% (0·0–45·9) | |
English | 916 | 62 | 6·8% (5·2–8·6) | 543 | 31 | 5·7% (3·9–8·0) | |
German | 421 | 22 | 5·2% (3·3–7·8) | .. | .. | .. | |
Dutch | .. | .. | .. | 224 | 5 | 2·2% (0·7–5·1) | |
French | .. | .. | .. | 150 | 14 | 9·3% (5·2–15·2) | |
Italian | 465 | 19 | 4·1% (2·5–6·3) | .. | .. | .. | |
Sardinian | 129 | 10 | 7·8% (3·8–13·8) | 10 | 0 | 0% (0·0–30·8) | |
Moldovan | 3 | 0 | 0% (0·0–70·8) | .. | .. | .. | |
Total (Europe) | 2223 | 174 | 7·8% (6·7–9·0) | 981 | 59 | 6·0% (4·6–7·7) | |
USA | |||||||
White | 890 | 48 | 5·4% (4·0–7·1) | .. | .. | .. | |
Hispanic | 72 | 6 | 8·3% (3·1–17·3) | .. | .. | .. | |
Black | 49 | 2 | 4·1% (0·5–14·0) | .. | .. | .. | |
Native American | 3 | 0 | 0% (0·0–70·8) | .. | .. | .. | |
Total (USA) | 1014 | 56 | 5·5% (4·2–7·1) | .. | .. | .. | |
Rest of the world | |||||||
Middle Eastern* | 1 | 0 | 0% (0·0–97·5) | .. | .. | .. | |
Indian | 31 | 0 | 0% (0·0–11·2) | 31 | 0 | 0% (0·0–11·2) | |
Asian | 238 | 0 | 0% (0·0–1·5) | 10 | 0 | 0% (0·0–30·8) | |
Pacific Islander/Guam | 90 | 0 | 0% (0·0–4·0) | .. | .. | .. | |
Australian* | 263 | 14 | 5·3% (2·9–8·8) | .. | .. | .. | |
Overall | 3860 | 244 | 6·3% (5·6–7·1) | 1022 | 59 | 5·8% (4·4–7·4) |